B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CYP2C9

MOLECULAR TARGET

cytochrome P450 family 2 subfamily C member 9

NCBI Gene: 1559295 compounds

CYP2C9 (cytochrome P450 family 2 subfamily C member 9) is targeted by 295 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CYP2C9

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Sulfaphenazole4.1160
2Disulfiram2.5612
3Clotrimazole2.4811
4Glyburide2.4010
5Phenytoin2.4010
6Gemfibrozil2.309
7Levonorgestrel2.309
8Norgestrel2.309
9Celecoxib2.208
10Finasteride2.208
11Phenylbutazone2.208
12Pueraria2.087
13Quercetin2.087
14Chlorhexidine2.087
15Danazol2.087
16Emodin Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as2.087
17Fenofibrate2.087
18Flutamide2.087
19Fulvestrant2.087
20Hexachlorophene2.087
21Loratadine2.087
22Meloxicam2.087
23Mestranol2.087
24Methoxsalen2.087
25Niclosamide2.087
26Rotenone2.087
27Budesonide1.956
28Dehydroepiandrosterone1.956
29Progesterone1.956
30Acetohexamide1.956
31Dehydroepiandrosterone1.956
32Edaravone1.956
33Ethoxyquin Antioxidant; also1.956
34Nisoldipine1.956
35Piperonyl Butoxide1.956
36Testosterone Propionate1.956
37Tolazamide1.956
38Tolbutamide1.956
39Troglitazone1.956
40Apigenin 5,7,4'-trihydroxy-flavone,1.795
41Thyroxine1.795
42Methylene Blue1.795
43myricetin-3-O-galactopyranoside [Supplementary Concept]1.795
44Vitamin1.795
4517 alpha-Hydroxyprogesterone Caproate Hydroxyprogesterone derivative that acts as1.795
46alpha-Linolenic Acid1.795
47Anastrozole1.795
48Chlormadinone Acetate1.795
49Chlorpropamide1.795
50Cimetidine1.795

Showing top 50 of 295 compounds. Use the BiohacksAI search to explore all CYP2C9 modulators.

About CYP2C9 as a Drug Target

CYP2C9 (cytochrome P450 family 2 subfamily C member 9) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 295 compounds with documented CYP2C9 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CYP2C9 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.